Harrisburg, Pennsylvania — A dozen companies that operate more than 200 nursing homes and long-term care facilities across Pennsylvania have agreed to stop automatically rejecting applicants because they take prescribed opioids.
The agreements, reached with Attorney General Dave Sunday’s office, require providers to evaluate each applicant individually instead of imposing blanket bans tied to medications like methadone. It’s a significant shift for an industry that has long treated opioid prescriptions as a liability red flag.
The crackdown traces back to a 2024 complaint filed by a woman whose mother was denied admission to multiple rehabilitation facilities after a hip fracture. Her reason for rejection? She had taken physician-prescribed methadone for chronic pain for two decades.
Under the Americans with Disabilities Act, facilities generally cannot refuse admission solely because a person takes legally prescribed medication to treat a disability. Providers are expected to conduct individualized assessments and consider reasonable accommodations, the attorney general’s office noted. Patients who take opioids for pain management, because of a disability, or for opioid use disorder all fall under that protection.
The numbers behind the problem
This isn’t an isolated grievance. A 2024 study of hospital referrals at two Baltimore hospitals found that patients with opioid use disorder faced far steeper odds of getting into skilled nursing care. Only about 31% of facilities agreed to accept their referrals, compared with roughly 47% for patients without the disorder. Those with OUD were also less likely to be discharged to a nursing home at all.
Fall risk and liability concerns drive much of the hesitation, and operators argue those worries aren’t baseless. But advocates say blanket rejection policies punish patients for treating legitimate medical conditions — and cross a legal line while doing it.
The access problem extends well beyond opioid patients. Medicare Advantage enrollees have also been found to face barriers, with patients getting shut out of top-rated facilities at higher rates than traditional Medicare beneficiaries.
For Pennsylvania’s providers, the message from the attorney general’s office is now clear: assess the patient, not the prescription list. Whether other states follow with similar enforcement remains an open question — but disability rights attorneys will be watching closely.
Discover more from Skilled Care Journal
Subscribe to get the latest posts sent to your email.


